CIK 0000946644 · Non-accelerated filer<br>Smaller reporting company
AIM ImmunoTech Inc.
Sign in to watch- Ticker
- AIM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 520845822
- Phone
- 352-448-7797
- Business address
- 2117 SW HIGHWAY 484, OCALA, FL, 32801
- Former names
- AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
- Open-market buys, last 90 days
- $39,251
- in 10 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$39,251. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-30 | RODINO III PETER W. COO,Secretary,Gen Counsel | Grant or award · Options | +100,000 | 100,000 | ||
| 2021-11-30 | LINTAL ELLEN M Chief Financial Officer | Grant or award · Options | +100,000 | 100,000 | ||
| 2021-11-24 | APPELROUTH STEWART Director | Grant or award | +19,379 | $1.29 | $25K | 111,917 |
| 2021-11-24 | EQUELS THOMAS K. CEO & President | Grant or award | +11,627 | $1.29 | $15K | 267,426 |
| 2021-11-23 | EQUELS THOMAS K. CEO & President | Grant or award | +11,194 | $1.34 | $15K | 255,799 |
| 2021-11-19 | EQUELS THOMAS K. CEO & President | Grant or award | +10,204 | $1.47 | $15K | 244,605 |
| 2021-11-17 | EQUELS THOMAS K. CEO & President | Grant or award | +9,146 | $1.64 | $15K | 234,401 |
| 2021-11-11 | MITCHELL WILLIAM M Director | Grant or award · Options | +50,000 | 50,000 | ||
| 2021-11-11 | APPELROUTH STEWART Director | Grant or award · Options | +50,000 | 50,000 | ||
| 2021-11-11 | EQUELS THOMAS K. CEO & President | Grant or award · Options | +300,000 | 300,000 | ||
| 2021-07-16 | EQUELS THOMAS K. CEO & President | Purchase | +15,625 | $1.92 | $30K | 225,255 |
| 2021-02-25 | APPELROUTH STEWART Director | Purchase | +10,638 | $2.35 | $25K | 92,538 |
| 2021-02-24 | EQUELS THOMAS K. CEO & President | Purchase | +11,062 | $2.26 | $25K | 209,630 |
| 2020-12-17 | EQUELS THOMAS K. CEO | Purchase | +14,535 | $1.72 | $25K | 198,568 |
| 2020-12-09 | RODINO III PETER W. COO, Secretary, Gen. Counsel | Grant or award · Options | +75,000 | 75,000 | ||
| 2020-12-09 | LINTAL ELLEN M Chief Financial Officer | Grant or award · Options | +75,000 | 75,000 | ||
| 2020-11-11 | EQUELS THOMAS K. CEO | Grant or award · Options | +300,000 | 300,000 | ||
| 2020-09-03 | EQUELS THOMAS K. CEO & President | Purchase | +12,316 | $2.03 | $25K | 184,033 |
| 2020-08-21 | EQUELS THOMAS K. CEO | Purchase | +10,730 | $2.33 | $25K | 171,717 |
| 2020-08-12 | APPELROUTH STEWART Director | Grant or award · Options | +50,000 | 50,000 |
Page 7 of 14 · 263 trades